KRAS mutations are involved in several cancers such as colorectal, pancreatic, non-small cell lung cancers, oesophageal adenocarcinoma/gastroesophageal junction cancer, invasive ductal carcinoma, stomach adenocarcinoma, and undifferentiated endometrial carcinoma [42]. Here, KRAS is linked to endometrial undifferentiated carcinoma.